1-3 of 3
Sirpa Leppä, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

STAT5 Signaling Is Associated with the Outcome of Follicular and Mantle Cell Lymphoma Patients Treated with Immunochemotherapy.

Sirpa Leppä, MD, PhD, Minna Taskinen, MSci, Antti Sommarhem, MD, Erkki Elonen, MD, PhD, Matti Nykter, PhD, Outi Monni, PhD, Tuomo Timonen, MD, PhD, Sampsa Hautaniemi, PhD, Marja-Liisa Karjalainen-Lindsberg, MD, PhD, Seppo Meri, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2626.
https://doi.org/10.1182/blood.V110.11.2626.2626
Published: 2007
Journal Articles

Cost-Effectiveness of Rituximab Maintenance Treatment Versus Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed Follicular Lymphoma (FL).

Sirpa Leppä, MD, PhD, Miika Linna, PhD, Heidi Nyman, MD, Eeva Taimela, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3337.
https://doi.org/10.1182/blood.V108.11.3337.3337
Published: 2006
Journal Articles

Does Rituximab Influence the Prognostic Effect of Germinal Centre Phenotype in Diffuse Large B-Cell Lymphoma?.

Heidi Nyman, MD, Marja-Liisa Karjalainen-Lindsberg, MD, Minna Taskinen, M.Sci, Mattias Berglund, M.Sci, Magdalena Adde, MD, Rose-Marie Amini, MD, Carl Blomqvist, MD, Gunilla Enblad, MD, Sirpa Leppä, MD
Journal: Blood
Blood (2006) 108 (11): 2743.
https://doi.org/10.1182/blood.V108.11.2743.2743
Published: 2006